Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,468 | 123 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $417.15 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $377.77 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $239.82 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $212.90 | 12 | $0 (2024) |
| Amgen Inc. | $207.14 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $169.17 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $152.19 | 9 | $0 (2024) |
| PFIZER INC. | $116.37 | 6 | $0 (2024) |
| Merck Sharp & Dohme LLC | $113.98 | 8 | $0 (2023) |
| SCPHARMACEUTICALS INC. | $101.79 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $927.47 | 48 | Novartis Pharmaceuticals Corporation ($180.48) |
| 2023 | $907.80 | 37 | GlaxoSmithKline, LLC. ($239.82) |
| 2022 | $296.69 | 17 | Boehringer Ingelheim Pharmaceuticals, Inc. ($61.05) |
| 2021 | $336.06 | 21 | Janssen Pharmaceuticals, Inc ($106.86) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Cardiology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $21.77 | General |
| Category: Cardiovascular | ||||||
| 11/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Cardiology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.94 | General |
| Category: Cardiovascular | ||||||
| 11/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| Category: Cardiovascular | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $20.38 | General |
| Category: Cardiovascular | ||||||
| 09/16/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Cardiology | ||||||
| 08/26/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: DIABETES | ||||||
| 08/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.48 | General |
| Category: Cardiovascular | ||||||
| 08/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/06/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $27.44 | General |
| Category: Not Applicable | ||||||
| 08/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Obesity | ||||||
| 07/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Cardiovascular | ||||||
| 07/29/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Cardiology | ||||||
| 07/22/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Cardiology | ||||||
| 07/09/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: DIABETES | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | WAINUA (Drug) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 255 | 352 | $55,616 | $18,884 |
| 2022 | 1 | 219 | 329 | $51,982 | $17,546 |
| 2021 | 1 | 225 | 315 | $49,770 | $17,633 |
| 2020 | 4 | 320 | 378 | $47,058 | $14,180 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 139 | 190 | $30,020 | $10,470 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 116 | 162 | $25,596 | $8,414 | 32.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 124 | 187 | $29,546 | $9,738 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 95 | 142 | $22,436 | $7,808 | 34.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 136 | 192 | $30,336 | $10,565 | 34.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 89 | 123 | $19,434 | $7,068 | 36.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 106 | 138 | $21,804 | $6,438 | 29.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 73 | 96 | $15,168 | $4,501 | 29.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 32 | 32 | $2,003 | $963.68 | 48.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 34 | $3,400 | $741.42 | 21.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 24 | 25 | $2,500 | $524.56 | 21.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Facility | 2020 | 15 | 15 | $702.00 | $460.27 | 65.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 21 | 21 | $978.00 | $318.65 | 32.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Facility | 2020 | 17 | 17 | $503.00 | $232.47 | 46.2% |
About Amy Nagar
Amy Nagar is a Nurse Practitioner healthcare provider based in Euclid, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/12/2018. The National Provider Identifier (NPI) number assigned to this provider is 1437624723.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Nagar has received a total of $2,468 in payments from pharmaceutical and medical device companies, with $927.47 received in 2024. These payments were reported across 123 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($2,468).
As a Medicare-enrolled provider, Nagar has provided services to 1,019 Medicare beneficiaries, totaling 1,374 services with total Medicare billing of $68,243. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Euclid, OH
- Active Since 10/12/2018
- Last Updated 01/11/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437624723
Products in Payments
- JARDIANCE (Drug) $417.15
- ELIQUIS (Drug) $215.96
- ENTRESTO (Drug) $208.65
- Repatha (Biological) $207.14
- XARELTO (Drug) $169.17
- LEQVIO (Drug) $169.12
- ZEJULA (Drug) $121.09
- JEMPERLI (Biological) $118.73
- VERQUVO (Drug) $113.98
- FUROSCIX (Drug) $101.79
- VYNDAQEL (Drug) $99.87
- FARXIGA (Drug) $87.58
- SYNERGY ABLATION SYSTEM (Device) $76.06
- Arcalyst (Drug) $69.71
- Vascepa (Drug) $59.21
- Ozempic (Drug) $42.60
- WAINUA (Drug) $40.58
- ZIO XT Patch (Device) $27.25
- BRILINTA (Drug) $24.03
- Wegovy (Drug) $22.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Euclid
Jessica Knezevich
Nurse Practitioner — Payments: $69.86
Elizabeth Maltese, Cnp, CNP
Nurse Practitioner — Payments: $25.00
Vincella Smith, Nurse Practitioner, NURSE PRACTITIONER
Nurse Practitioner — Payments: $24.99
Olga Ramos, Cnp, CNP
Nurse Practitioner
Amber Strickland
Nurse Practitioner